Product Name:

NebuPeptide™ Semaglutide Intermediated P29

Catalog Number:

NBS-233907

Description:

NebuPeptide™ Semaglutide Intermediated P29 (CAT#NBS-233907) is synthesized in accordance with the Semaglutide sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Semaglutide Intermediated ranging from milligrams to kilograms.

Peptide Name:

Semaglutide Intermediated P29 (索马鲁肽中间体)

Alias:

Glycine,L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-ChemicalbookL-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;3-31]-Sermaglutide main chain;SemaglutideintermediateP29;Arg34GLP-1

CAS Number:

1169630-82-3

Formula:

C142H216N38O45

Molecular Weight:

3175.46

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

To get more information, please contact us freely.